ATE362783T1 - Verwendung von dapson als neuroprotektor bei zerebralinfarkt - Google Patents
Verwendung von dapson als neuroprotektor bei zerebralinfarktInfo
- Publication number
- ATE362783T1 ATE362783T1 AT04721040T AT04721040T ATE362783T1 AT E362783 T1 ATE362783 T1 AT E362783T1 AT 04721040 T AT04721040 T AT 04721040T AT 04721040 T AT04721040 T AT 04721040T AT E362783 T1 ATE362783 T1 AT E362783T1
- Authority
- AT
- Austria
- Prior art keywords
- dapsone
- neuroprotector
- cerebral infarction
- stroke
- brain stroke
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Mobile Radio Communication Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA03006549A MXPA03006549A (es) | 2003-07-22 | 2003-07-22 | Uso de la dapsona como neuroprotector en el infarto cerebral. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE362783T1 true ATE362783T1 (de) | 2007-06-15 |
Family
ID=34075071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04721040T ATE362783T1 (de) | 2003-07-22 | 2004-03-16 | Verwendung von dapson als neuroprotektor bei zerebralinfarkt |
Country Status (15)
Country | Link |
---|---|
US (1) | US8268893B2 (de) |
EP (1) | EP1655055B1 (de) |
JP (1) | JP5452844B2 (de) |
CN (1) | CN100500246C (de) |
AT (1) | ATE362783T1 (de) |
BR (1) | BRPI0412212A (de) |
CA (1) | CA2533181C (de) |
DE (1) | DE602004006633T2 (de) |
EA (1) | EA012174B1 (de) |
EC (1) | ECSP066316A (de) |
ES (1) | ES2287713T3 (de) |
HK (1) | HK1098086A1 (de) |
MX (1) | MXPA03006549A (de) |
PT (1) | PT1655055E (de) |
WO (1) | WO2005007239A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2009004635A (es) * | 2009-04-29 | 2010-10-29 | Univ Autonoma Metropolitana | Formas farmaceúticas solubles de la n,n´-diamino-difenilsulfona para su uso óptimo en el tratamiento de diversas enfermedades. |
KR101875705B1 (ko) | 2011-12-07 | 2018-07-06 | 삼성전자주식회사 | 디아미노디페닐술폰을 포함하는 근육 소모 관련 질환의 예방 또는 치료용 약학적 조성물 |
CN104177611A (zh) * | 2013-05-27 | 2014-12-03 | 韩文毅 | 一种非线性的聚合物及其制备和用途 |
CN104177610A (zh) * | 2013-05-27 | 2014-12-03 | 韩文毅 | 一种非线性的聚合物及其制备和用途 |
CN104069091A (zh) * | 2014-07-09 | 2014-10-01 | 崔德华 | 氨苯砜在保护血脑屏障完整性中的应用 |
KR20160047318A (ko) * | 2014-10-22 | 2016-05-02 | 삼성전자주식회사 | 다프손을 포함하는, 개체의 부위에서 혈관신생을 자극시키기 위한 조성물 및 그의 용도 |
KR20200107899A (ko) * | 2019-11-16 | 2020-09-16 | 이종훈 | 알츠하이머병 혹은 뇌졸중의 뉴로인플라마섬의 치료제로서 디디에스 혹은 그 유도체 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5532219A (en) * | 1991-04-23 | 1996-07-02 | The University Of British Columbia | Dapsone and promin for the treatment of dementia |
TR200100068T2 (tr) * | 1998-07-15 | 2001-06-21 | Jomaa,Hassan | Fosforlu organik bileşikler ve kullanımları |
GB2362101A (en) * | 2000-05-12 | 2001-11-14 | Astrazeneca Ab | Treatment of chronic obstructive pulmonary disease |
-
2003
- 2003-07-22 MX MXPA03006549A patent/MXPA03006549A/es active IP Right Grant
-
2004
- 2004-03-16 WO PCT/MX2004/000018 patent/WO2005007239A1/es active IP Right Grant
- 2004-03-16 BR BRPI0412212-7A patent/BRPI0412212A/pt not_active IP Right Cessation
- 2004-03-16 EA EA200600272A patent/EA012174B1/ru not_active IP Right Cessation
- 2004-03-16 CA CA2533181A patent/CA2533181C/en not_active Expired - Fee Related
- 2004-03-16 JP JP2006521015A patent/JP5452844B2/ja not_active Expired - Fee Related
- 2004-03-16 PT PT04721040T patent/PT1655055E/pt unknown
- 2004-03-16 US US10/565,309 patent/US8268893B2/en not_active Expired - Fee Related
- 2004-03-16 AT AT04721040T patent/ATE362783T1/de not_active IP Right Cessation
- 2004-03-16 DE DE602004006633T patent/DE602004006633T2/de not_active Expired - Lifetime
- 2004-03-16 ES ES04721040T patent/ES2287713T3/es not_active Expired - Lifetime
- 2004-03-16 CN CNB2004800264451A patent/CN100500246C/zh not_active Expired - Fee Related
- 2004-03-16 EP EP04721040A patent/EP1655055B1/de not_active Expired - Lifetime
-
2006
- 2006-01-25 EC EC2006006316A patent/ECSP066316A/es unknown
-
2007
- 2007-04-25 HK HK07104433.0A patent/HK1098086A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2006528175A (ja) | 2006-12-14 |
CA2533181C (en) | 2012-08-07 |
BRPI0412212A (pt) | 2006-08-22 |
ECSP066316A (es) | 2006-10-25 |
EP1655055A1 (de) | 2006-05-10 |
CN1852749A (zh) | 2006-10-25 |
CN100500246C (zh) | 2009-06-17 |
MXPA03006549A (es) | 2004-03-18 |
WO2005007239A1 (es) | 2005-01-27 |
JP5452844B2 (ja) | 2014-03-26 |
DE602004006633T2 (de) | 2008-01-31 |
WO2005007239B1 (es) | 2005-05-06 |
PT1655055E (pt) | 2007-08-31 |
ES2287713T3 (es) | 2007-12-16 |
EA012174B1 (ru) | 2009-08-28 |
DE602004006633D1 (de) | 2007-07-05 |
US20100063159A1 (en) | 2010-03-11 |
CA2533181A1 (en) | 2005-01-27 |
EA200600272A1 (ru) | 2006-10-27 |
EP1655055B1 (de) | 2007-05-23 |
HK1098086A1 (en) | 2007-07-13 |
US8268893B2 (en) | 2012-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0117645D0 (en) | Therapeutic stratergies for prevention and treatment of alzheimers disease | |
ECSP066316A (es) | Uso de la dapsona como neuroprotector en el infarto cerebral | |
EP1463531A4 (de) | Verfahren zur hemmung okularer vorgänge | |
WO2005113590A3 (en) | Bmp10 propeptides and related methods | |
HRP20020593B1 (en) | Brain, spinal and nerve injury treatment | |
DE60231804D1 (de) | Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomöostase störungen | |
BR0114054A (pt) | Método para tratar alergias usando pirazóis substituìdos | |
ATE415968T1 (de) | 3,11b-cis-dihydrotetrabanezin zur behandlung von schizophrenie und anderen psychosen | |
BRPI0316438C1 (pt) | uso de eritropoietina em doenças cardíacas | |
DE602006008643D1 (de) | Ophthalmische Zusammensetzungen von parasympathischen Stimulantia und Entzündungshemmer zur Verwendung bei der Behandlung von Presbyopie | |
DK1490066T3 (da) | Anvendelse af ranolazin til fremstilling af et medikament til behandling af arytmier | |
NO20076241L (no) | Terapier for vaskulaere sykdommer | |
WO2001058476A3 (en) | Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity | |
DE60304695D1 (de) | 7-ARYLSULFONAMID-2,3,4,5-TETRAHYDRO-1H-BENZOiDöAZEPINE MIT 5-HT6 REZEPTOR AFFINITÄT ZUR BEHANDLUNG VON ZENTRALNERVENSYSTEMERKRANKUNGEN | |
ATE424825T1 (de) | Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten | |
ATE265454T1 (de) | Phenyloxazol-1,4-diazabicyclo(3.2.2)nonanderiva e,ihre herstellung und ihre therapeutische verwendung | |
ATE556707T1 (de) | Phosphodiesesterase 4 inhibitoren zur behandlung eines kognitiven defizits | |
DE60333205D1 (de) | Histaminika zur behandlung von allergischer rhinitis | |
ATE552251T1 (de) | Thiophen- und furanverbindungen | |
SI1744736T1 (sl) | Postopek za zdravljenje težav s suhimi očmi in uveitisa | |
PL376056A1 (en) | 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases | |
WO2002099422A3 (en) | Individualization of therapy with alzheimer's disease agents | |
ITTO20000674A0 (it) | Composizioni a base di aminoacidi, atte al trattamento dell'insufficienza cardiaca. | |
DE60228988D1 (de) | Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen | |
DE60234130D1 (de) | Fahrradsitz |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |